Keyphrases
Adverse Effects
20%
Amnion
60%
Chorion
20%
Cyclooxygenase Inhibitors
20%
Cyclooxygenase-1 (COX-1)
60%
Cyclooxygenase-2
100%
Cyclooxygenase-2 Inhibitors
40%
Decidua
20%
Enhanced Expression
20%
Isozymes
20%
Labouring Women
20%
Myometrium
20%
NS-398
20%
Preterm Delivery
20%
Prostaglandin E2
40%
Prostaglandin Production
100%
SC-560
20%
Selective Inhibitor
100%
Tocolytics
20%
Women in Labor
20%
Medicine and Dentistry
Adverse Event
20%
Amnion
60%
Chorion
20%
Cyclooxygenase 1
20%
Cyclooxygenase 1 Inhibitor
20%
Cyclooxygenase 2
100%
Cyclooxygenase 2 Inhibitor
20%
Decidua
20%
In Vitro Production
20%
Isoenzyme
20%
Myometrium
20%
Premature Labor
20%
Prostaglandin
100%
Prostaglandin E2
40%
Prostaglandin Synthase
100%
Prostaglandin Synthase Inhibitor
20%
Uterus Spasmolytic Agent
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
COX-2 Inhibitor
20%
Cyclooxygenase 1
20%
Cyclooxygenase 1 Inhibitor
20%
Cyclooxygenase 2
100%
Isoenzyme
20%
NS-398
20%
Premature Labor
20%
Prostaglandin
100%
Prostaglandin E2
40%
Prostaglandin Synthase
100%
Prostaglandin Synthase Inhibitor
20%
Uterus Spasmolytic Agent
20%